News
GSK obtains Japanese approval for Encruse Ellipta to treat COPD
GlaxoSmithKline (GSK) has obtained Japanese approval for its Encruse Ellipta (umeclidinium). The Japanese Ministry of Health, Labour and Welfare (MHLW) granted...
Press Releases
Multisorb to Attend Interphex 2015
Multisorb Technologies has announced it will be exhibiting at Interphex in New York. The event will take place from 20-22 April...
News
FDA grants orphan drug designation for Aduro’s immuno-oncology product candidate
Aduro Biotech has received orphan drug designation from US Food and Drug Administration (FDA) for its immuno-oncology product candidate CRS-207 to treat mesothelioma. ...
Press Releases
New Flavour Capabilities at RSSL
Reading Scientific Services (RSSL) will launch a new suite of flavour services in April, which include sophisticated flavour analysis. Analysis services...
News
India’s Sun Pharma completes $3.2bn merger deal with Ranbaxy
India-based Sun Pharmaceutical Industries has completed the merger with Ranbaxy, as part of a $3.2bn deal. Sun has started integration of...
News
Sanofi Pasteur’s Quadracel approved to treat children between the ages of four and six
Sanofi Pasteur has received approval from US Food and Drug Administration (FDA) for its Quadracel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Absorbed and...
News
Agios’s pyruvate kinase deficiency treatment receives FDA orphan drug designation
Agios Pharmaceuticals has received orphan drug designation from the US Food and Drug Administration (FDA) for its investigational medicine AG-348 to treat pyruvate kinase...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read